天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)]

SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)] Struktur
CAS-Nr.
Englisch Name:
SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)]
Synonyma:
TOSLAB 869166;SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)]
CBNumber:
CB3309854
Summenformel:
C25H27ClN4O3
Molgewicht:
466.96
MOL-Datei:
Mol file

SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)] Eigenschaften

Sicherheit

SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)] Chemische Eigenschaften,Einsatz,Produktion Methoden

SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)] Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)] Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Technology for Organic Synthesis Laboratory TOSLab --
Russia 6064 69

  • SPIRO[1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE-5,5'-(9'-CHLORO-3'-(2',3'-DIMETHYLPHENYL)-2',3',4',4A',5',6'-HEXAHYDRO-1'H-PYRAZINO[1',2'-A']QUINOLINE)]
  • TOSLAB 869166
Copyright 2019 ? ChemicalBook. All rights reserved